CoChat

Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation

Open access
Sham, Ronald L., Phatak, Pradyumna D., Nemeth, Elizabeta, Ganz, Tomas · 2009 · Blood
Cited by 74

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

To the editor: The different genetic forms of hereditary hemochromatosis share as their pathogenic mechanisms the deficiency or dysregulation of the hormone hepcidin or defects involving the hepcidin receptor, ferroportin.1 Ferroportin is the sole known cellular iron exporter in humans and is present on enterocytes, macrophages, and hepatocytes.2 Normally, the cell-surface concentration of ferroportin is regulated by its interaction with hepcidin. Hepcidin binding triggers the internalization and degradation of the ferroportin-hepcidin complex, causing a decrease in cellular iron release into plasma.3 Mutations in the ferroportin (SLC40A1) gene cause iron overload syndromes with autosomal dominant transmission.4 Ferroportin mutations cause at least 2 distinct phenotypes, depending on the functional alteration of the protein. One subtype of ferroportin mutations, predominantly involving residues located on the putative cytoplasmic side or in transmembrane segments (eg, V162del, D157G, G80S, G490D), results in the loss of iron export function.5 This leads to increased macrophage iron and elevated serum ferritin, but normal transferrin saturation. This phenotype, referred to as “ferroportin disease,” does not appear to have significant morbidity. A distinct ferroportin-related phenotype, similar to classical hereditary hemochromatosis, is associated with gain-of-function mutations (eg N144D/T/H, Y64N, C326S/Y).6,7 In vitro evidence (companion manuscript, Fernandes et al8) indicates that these mutations cause ferroportin's resistance to the effects of hepcidin. N144D/T and Y64N mutations prevent internalization of hepcidin-ferroportin complex while C326S mutation completely ablates hepcidin binding to ferroportin. We previously reported that C326S mutation results in the most severe iron overload phenotype with early age of onset.6 In this study, we measured hepcidin and iron indices in members of the family carrying heterozygous C326S mutations.6 Hepcidin was measured by competitive ELISA8 (Intrinsic LifeSciences, La Jolla, CA). The subjects had already been treated by phlebotomy and had normalized iron stores, as assessed by serum ferritin, but their transferrin saturation remained high (Table 1). One of the patients (IIIC) has become iron-deficient due to phlebotomy combined with menstrual blood loss. Except for patient IIIC, all affected family members had serum and urinary hepcidin concentrations in the upper limit of the normal range or above (Table 1). These relatively high hepcidin levels are probably a consequence of patients' elevated transferrin saturation. Only IIIC patient had lower hepcidin, likely reflecting the appropriate response of hepcidin to iron deficiency. The high levels of hepcidin in patients with C326S despite relatively depleted iron stores are in contrast to the low or undetectable hepcidin levels observed in treated patients with HFE, transferrin receptor 2, or hemojuvelin hemochromatosis.9–11 Thus, our study provides the first direct evidence that hereditary hemochromatosis can be caused by the resistance of ferroportin to hepcidin. The absence of hepcidin binding to mutant ferroportin in C326S patients leads to excessive ferroportin activity in duodenal enterocytes and unrestrained dietary iron absorption, which would account for the early-onset systemic iron overload similar to that seen in juvenile hemochromatosis. Our findings support the concept that hereditary hemochromatosis with parenchymal iron-loading phenotype can be caused by either hepcidin deficiency or resistance to the effect of hepcidin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2009-04-216226

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 74

Metadata

Authors
Sham, R. L., Phatak, P. D., Nemeth, E., & Ganz, T.
Venue
Blood
Published
2009-07-09
Volume
114
Issue
2
Pages
493-494
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1970736399
Cited by
74
References
5
FWCI
3.96
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. https://app.cochat.ai/papers/10.1182/blood-2009-04-216226
The paper
Sham, R. L., Phatak, P. D., Nemeth, E., & Ganz, T. (2009). Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood. https://doi.org/10.1182/blood-2009-04-216226

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.